Franklin Resources’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2M | Sell |
225,600
-272,199
| -55% | -$41.3M | 0.01% | 750 |
|
|
2025
Q1 | $74.9M | Sell |
497,799
-149,981
| -23% | -$22.6M | 0.02% | 473 |
|
|
2024
Q4 | $120M | Sell |
647,780
-16,675
| -3% | -$3.08M | 0.03% | 405 |
|
|
2024
Q3 | $128M | Sell |
664,455
-693
| -0.1% | -$134K | 0.04% | 386 |
|
|
2024
Q2 | $137M | Buy |
665,148
+13,343
| +2% | +$2.76M | 0.04% | 342 |
|
|
2024
Q1 | $177M | Sell |
651,805
-111,210
| -15% | -$30.1M | 0.06% | 304 |
|
|
2023
Q4 | $180M | Sell |
763,015
-18,486
| -2% | -$4.37M | 0.08% | 256 |
|
|
2023
Q3 | $153M | Buy |
781,501
+56,248
| +8% | +$11M | 0.08% | 273 |
|
|
2023
Q2 | $152M | Sell |
725,253
-934
| -0.1% | -$196K | 0.07% | 298 |
|
|
2023
Q1 | $147M | Buy |
726,187
+30,975
| +4% | +$6.25M | 0.07% | 300 |
|
|
2022
Q4 | $151M | Buy |
695,212
+50,044
| +8% | +$10.9M | 0.08% | 289 |
|
|
2022
Q3 | $127M | Buy |
645,168
+222,387
| +53% | +$43.8M | 0.07% | 324 |
|
|
2022
Q2 | $90.5M | Buy |
422,781
+4,496
| +1% | +$962K | 0.04% | 404 |
|
|
2022
Q1 | $119M | Sell |
418,285
-74,628
| -15% | -$21.2M | 0.05% | 395 |
|
|
2021
Q4 | $186M | Buy |
492,913
+70,113
| +17% | +$26.4M | 0.07% | 318 |
|
|
2021
Q3 | $174M | Buy |
422,800
+40,732
| +11% | +$16.8M | 0.07% | 325 |
|
|
2021
Q2 | $141M | Buy |
382,068
+9,073
| +2% | +$3.36M | 0.05% | 378 |
|
|
2021
Q1 | $108M | Buy |
372,995
+15,534
| +4% | +$4.5M | 0.04% | 417 |
|
|
2020
Q4 | $89.3M | Buy |
357,461
+219,383
| +159% | +$54.8M | 0.04% | 451 |
|
|
2020
Q3 | $31.3M | Buy |
+138,078
| New | +$31.3M | 0.02% | 664 |
|
|
2020
Q2 | – | Sell |
-101,455
| Closed | -$12.8M | – | 1689 |
|
|
2020
Q1 | $12.8M | Buy |
+101,455
| New | +$12.8M | 0.01% | 760 |
|
|
2019
Q4 | – | Sell |
-14,259
| Closed | -$1.89M | – | 1535 |
|
|
2019
Q3 | $1.89M | Buy |
14,259
+10,106
| +243% | +$1.34M | ﹤0.01% | 1176 |
|
|
2019
Q2 | $589K | Buy |
+4,153
| New | +$589K | ﹤0.01% | 1347 |
|